about
The evi-1 oncoprotein inhibits c-Jun N-terminal kinase and prevents stress-induced cell deathMutational analyses of the AML1 gene in patients with myelodysplastic syndromePrimary CNS CCND1/MYC-Positive Double-Hit B-Cell Lymphoma: A Case Report and Review of the Literature.Advance and stagnation in the treatment of patients with lymphoma and myeloma: Analysis using population-based cancer registry data in Japan from 1993 to 2006.Identification of a novel fusion gene, TTL, fused to ETV6 in acute lymphoblastic leukemia with t(12;13)(p13;q14), and its implication in leukemogenesis.Prednisone versus high-dose dexamethasone for untreated primary immune thrombocytopenia. A retrospective study of the Japan Hematology & Oncology Clinical Study Group.Prognostic significance of CD20 expression and Epstein-Barr virus (EBV) association in classical Hodgkin lymphoma in Japan: a clinicopathologic study.Detection of the G17V RHOA mutation in angioimmunoblastic T-cell lymphoma and related lymphomas using quantitative allele-specific PCR.Prognostic significance of pleural or pericardial effusion and the implication of optimal treatment in primary mediastinal large B-cell lymphoma: a multicenter retrospective study in Japan.The corepressor mSin3A regulates phosphorylation-induced activation, intranuclear location, and stability of AML1.Male predominance among Japanese adult patients with late-onset hemorrhagic cystitis after hematopoietic stem cell transplantation.Breakthrough viridans streptococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients receiving levofloxacin prophylaxis in a Japanese hospital.A case report of the histologic transformation of primary follicular lymphoma of the duodenumIdentification of cell-type-specific mutations in nodal T-cell lymphomas.A phase 1/2 study of carfilzomib in Japanese patients with relapsed and/or refractory multiple myelomaGuidelines for the management of cutaneous lymphomas (2011): a consensus statement by the Japanese Skin Cancer Society - Lymphoma Study Group.Angioimmunoblastic T-cell lymphoma with intramedullary production of platelet-derived growth factor and possibly complicating myelofibrosis: report of a case with review of the literature.[Recommendation for the optimal use of bendamustine in Japan].Gain-of-function mutations and copy number increases of Notch2 in diffuse large B-cell lymphoma.Phase I/II Study of Pralatrexate in Japanese Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma.ALK-positive large B-cell lymphoma: identification of EML4-ALK and a review of the literature focusing on the ALK immunohistochemical staining pattern.Aberrant PD-L1 expression through 3'-UTR disruption in multiple cancers.Clinical and Microbiological Characteristics of Breakthrough Candidemia in Allogeneic Hematopoietic Stem Cell Transplant Recipients in a Japanese Hospital.Malignant lymphoma: pathophysiology and current therapy.Successful Treatment of Pulmonary Mucormycosis Caused by Cunninghamella bertholletiae with High-Dose Liposomal Amphotericin B (10 mg/kg/day) Followed by a Lobectomy in Cord Blood Transplant Recipients.A multicenter, single-arm, Phase II clinical trial of bendamustine monotherapy in patients with chronic lymphocytic leukemia in Japan.Bendamustine plus rituximab for previously untreated patients with indolent B-cell non-Hodgkin lymphoma or mantle cell lymphoma: a multicenter Phase II clinical trial in Japan.AML1 is functionally regulated through p300-mediated acetylation on specific lysine residues.The t(3;21) fusion product, AML1/Evi-1 blocks AML1-induced transactivation by recruiting CtBP.Long-term survival following autologous and allogeneic stem cell transplantation for blastic plasmacytoid dendritic cell neoplasm.Hematopoietic stem cell transplantation for cutaneous T-cell lymphoma: Summary of 11 cases from two facilities in Japan and Brazil.A prospective feasibility study of primary prophylaxis against invasive fungal disease with voriconazole following umbilical cord blood transplantation with fludarabine-based conditioning.High-dose chemotherapy with autologous stem cell transplantation for elderly patients with relapsed/refractory diffuse large B cell lymphoma: a nationwide retrospective study.High-dose chemotherapy followed by autologous stem cell transplantation for relapsed/refractory primary mediastinal large B-cell lymphoma.Somatic RHOA mutation in angioimmunoblastic T cell lymphoma.Epstein-Barr virus-associated mononucleosis caused by weekly low-dose methotrexate therapy in a rheumatoid arthritis patient.The role of hematopoietic stem cell transplantation for relapsed and refractory Hodgkin lymphoma.Durable remission after the administration of rituximab for EBV-negative, diffuse large B-cell lymphoma following autologous peripheral blood stem cell transplantation for angioimmunoblastic T-cell lymphoma.Comparison of outcomes between autologous and allogeneic hematopoietic stem cell transplantation for peripheral T-cell lymphomas with central review of pathology.Autologous stem cell transplantation with PCR-negative graft would be associated with a favorable outcome in core-binding factor acute myeloid leukemia.
P50
Q22254262-53CF3811-B6A4-459E-BA63-40ABCF93E13BQ28217097-53F642CB-B889-488A-8A5B-636C4B9B4169Q30790383-BFAE5087-B9A1-4371-9F6F-EC0D2452CF21Q30895580-F2DED054-BC1A-49F3-8260-CBB99AA832EFQ33187135-5FD147EE-72E1-4E99-AF4D-9ACCD3136F99Q33407822-F9534238-052B-4BB7-880E-5462E052A738Q33416615-3E2B9638-DDF4-4FE0-8375-5F564CD791E1Q34332071-D25BE7D3-9559-4CBA-A3C4-AF3589F35715Q34649109-D0BCBC28-DF48-4DE1-8553-B4F243CB513EQ35544219-6953AC32-0577-45D6-9A29-7228560DBA87Q35597076-3C70B215-AAF1-42BC-818E-FD6C4C9AA221Q36096410-03A8D728-3B15-463C-B823-D6D6E20EF6FEQ36193830-0163B541-7685-4B7E-A963-F07DE9601D32Q36269008-014517A0-014A-4026-93E7-EB7E2FC7390FQ36671445-5EB2B7AD-9E55-4DE9-9310-A4C03DF8ACF1Q38035410-01938455-B430-4D36-9E90-B95E5EFFF077Q38120989-3672986C-A518-4CC3-B2A4-DA3405F22419Q38200483-BF370046-93E9-40C4-9479-CB84FDA2F14DQ38354055-A2C8D727-6B10-414A-9E63-D29063843F7DQ38644090-9A20786B-BDE4-4B20-9168-4B120EF29A41Q38701797-2368FA4E-6668-4CAB-85B2-D6D4821587ABQ38765494-ACA3F103-661D-4DAA-946E-7CFC0A84E0B7Q39003533-9A5478C2-586D-442B-B682-922F5C8AE796Q39358460-5A7FE303-DB78-496E-96D2-A5F35B0B6C9CQ40186737-B0A830F6-DF6D-439A-A668-D746D0F8DCCAQ40345871-AEDFE8AB-4DD1-437F-BA5D-F8BB9BDC4217Q40449915-2A392B45-576B-416E-A429-5CA6A19CBD35Q40594028-18F6193B-910D-47D4-85A4-AB16D63C94F7Q40736865-1D6C6CF4-623A-4DB3-9DE0-5685B023AA6DQ41006736-4A9D0B69-D2AF-4D06-935D-3D82C386A161Q41099857-40420077-C865-40F4-A209-FC1A54F27E49Q42222406-E547DFC1-DB59-4567-976A-A12C6E3C890AQ42229931-71A9AAEC-840D-4C0B-8904-2D9558ABB068Q42540294-A51C1998-00F1-4D15-BAC6-12723A33A42FQ42808195-83A80E87-0950-44F8-B96E-BF8DC58363E9Q43691027-3F01DE86-26B8-48BB-AE39-EDB858F2A191Q43716206-383813A8-C30C-4761-B501-492DE608A6B9Q45150424-A7F5A2EA-5E2E-4175-96FE-87955D248E58Q46159472-9B075282-80EF-4653-BB16-4B9B42B46D78Q46305384-2EFD85C5-E601-455D-BCC2-1B87596A1DB3
P50
description
researcher
@en
name
K Izutsu
@en
K Izutsu
@nl
type
label
K Izutsu
@en
K Izutsu
@nl
prefLabel
K Izutsu
@en
K Izutsu
@nl
P106
P31
P496
0000-0001-9129-8057